This paper examines the PDMA, the development of electronic pedigrees, and the impact of these regulations on state legislation. The growing problem of drug counterfeiting requires that the FDA and state legislature take action to protect the American drug supply and consumers of prescription drugs. While it recognizes that many concerns still must be addressed, the FDA insists that these concerns will no longer delay the implementation of the e-pedigree program.

 

To request a copy, click here.